These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. HDL subpopulations containing apoA-I without apoA-II (LpA-I) in patients with angiographically proven coronary artery disease. Kuchta A; Strzelecki A; Ćwiklińska A; Gruchała M; Zdrojewski Z; Kortas-Stempak B; Wieczorek E; Gliwińska A; Dąbkowski K; Jankowski M J Cardiol; 2017 Mar; 69(3):523-528. PubMed ID: 27169356 [TBL] [Abstract][Full Text] [Related]
3. High-Density Lipoprotein Subfractions and Cholesterol Efflux Capacities After Infusion of MDCO-216 (Apolipoprotein A-IMilano/Palmitoyl-Oleoyl-Phosphatidylcholine) in Healthy Volunteers and Stable Coronary Artery Disease Patients. Kempen HJ; Asztalos BF; Moerland M; Jeyarajah E; Otvos J; Kallend DG; Bellibas SE; Wijngaard PL Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):736-42. PubMed ID: 26916733 [TBL] [Abstract][Full Text] [Related]
4. Markedly accelerated catabolism of apolipoprotein A-II (ApoA-II) and high density lipoproteins containing ApoA-II in classic lecithin: cholesterol acyltransferase deficiency and fish-eye disease. Rader DJ; Ikewaki K; Duverger N; Schmidt H; Pritchard H; Frohlich J; Clerc M; Dumon MF; Fairwell T; Zech L J Clin Invest; 1994 Jan; 93(1):321-30. PubMed ID: 8282802 [TBL] [Abstract][Full Text] [Related]
5. Relationship of high density lipoprotein composition to plasma lecithin:cholesterol acyltransferase concentration in men. Miller NE; Rajput-Williams J; Nanjee MN; Samuel L; Albers JJ Atherosclerosis; 1988 Feb; 69(2-3):123-9. PubMed ID: 3126747 [TBL] [Abstract][Full Text] [Related]
6. Molecular mechanism of reverse cholesterol transport: reaction of pre-beta-migrating high-density lipoprotein with plasma lecithin/cholesterol acyltransferase. Nakamura Y; Kotite L; Gan Y; Spencer TA; Fielding CJ; Fielding PE Biochemistry; 2004 Nov; 43(46):14811-20. PubMed ID: 15544352 [TBL] [Abstract][Full Text] [Related]
7. Increased plasma lipid-poor apolipoprotein A-I in patients with coronary artery disease. Suzuki M; Wada H; Maeda S; Saito K; Minatoguchi S; Saito K; Seishima M Clin Chem; 2005 Jan; 51(1):132-7. PubMed ID: 15550473 [TBL] [Abstract][Full Text] [Related]
8. Plasma high density lipoproteins and coronary artery disease. Sodhi HS; Lee G; Joye JA; Clifford CK; Kudchodkar BJ; Terai Y; Shaw I; Mason DT Adv Myocardiol; 1980; 2():513-25. PubMed ID: 7423063 [TBL] [Abstract][Full Text] [Related]
9. Reverse cholesterol transport in plasma of patients with different forms of familial HDL deficiency. von Eckardstein A; Huang Y; Wu S; Funke H; Noseda G; Assmann G Arterioscler Thromb Vasc Biol; 1995 May; 15(5):691-703. PubMed ID: 7749883 [TBL] [Abstract][Full Text] [Related]
10. Distribution of ApoA-I-containing HDL subpopulations in patients with coronary heart disease. Asztalos BF; Roheim PS; Milani RL; Lefevre M; McNamara JR; Horvath KV; Schaefer EJ Arterioscler Thromb Vasc Biol; 2000 Dec; 20(12):2670-6. PubMed ID: 11116070 [TBL] [Abstract][Full Text] [Related]
11. Distribution of subclasses of HDL containing apoA-I without apoA-II (LpA-I) in normolipidemic men and women. Duverger N; Rader D; Brewer HB Arterioscler Thromb; 1994 Oct; 14(10):1594-9. PubMed ID: 7918309 [TBL] [Abstract][Full Text] [Related]
12. Lecithin:cholesterol acyltransferase reaction on cellular lipid released by free apolipoprotein-mediated efflux. Czarnecka H; Yokoyama S Biochemistry; 1995 Apr; 34(13):4385-92. PubMed ID: 7703252 [TBL] [Abstract][Full Text] [Related]
13. Hyperhomocysteinemia decreases circulating high-density lipoprotein by inhibiting apolipoprotein A-I Protein synthesis and enhancing HDL cholesterol clearance. Liao D; Tan H; Hui R; Li Z; Jiang X; Gaubatz J; Yang F; Durante W; Chan L; Schafer AI; Pownall HJ; Yang X; Wang H Circ Res; 2006 Sep; 99(6):598-606. PubMed ID: 16931800 [TBL] [Abstract][Full Text] [Related]
14. ApoA-I/phosphatidylcholine discs remodels fast-migrating HDL into slow-migrating HDL as characterized by capillary isotachophoresis. Zhang B; Miura S; Fan P; Kumagai K; Takeuchi K; Uehara Y; McMahon M; Rye KA; Saku K Atherosclerosis; 2006 Sep; 188(1):95-101. PubMed ID: 16307746 [TBL] [Abstract][Full Text] [Related]
15. Evidence against alterations in Lecithin:cholesterol acyltransferase (LCAT) activity in familial combined hyperlipidemia. Ribalta J; La Ville AE; Vallvé JC; Girona J; Masana L Atherosclerosis; 1998 Jun; 138(2):383-9. PubMed ID: 9690923 [TBL] [Abstract][Full Text] [Related]
16. Relation of the level of high-density lipoprotein subfractions to the presence and extent of coronary artery disease. Drexel H; Amann FW; Rentsch K; Neuenschwander C; Luethy A; Khan SI; Follath F Am J Cardiol; 1992 Aug; 70(4):436-40. PubMed ID: 1642180 [TBL] [Abstract][Full Text] [Related]
17. Identification of a sequence of apolipoprotein A-I associated with the efflux of intracellular cholesterol to human serum and apolipoprotein A-I containing particles. Sviridov D; Pyle L; Fidge N Biochemistry; 1996 Jan; 35(1):189-96. PubMed ID: 8555173 [TBL] [Abstract][Full Text] [Related]
18. Effect of apolipoprotein A-I lipidation on the formation and function of pre-beta and alpha-migrating LpA-I particles. Sparks DL; Frank PG; Braschi S; Neville TA; Marcel YL Biochemistry; 1999 Feb; 38(6):1727-35. PubMed ID: 10026251 [TBL] [Abstract][Full Text] [Related]
19. LCAT-dependent conversion of prebeta1-HDL into alpha-migrating HDL is severely delayed in hemodialysis patients. Miida T; Miyazaki O; Hanyu O; Nakamura Y; Hirayama S; Narita I; Gejyo F; Ei I; Tasaki K; Kohda Y; Ohta T; Yata S; Fukamachi I; Okada M J Am Soc Nephrol; 2003 Mar; 14(3):732-8. PubMed ID: 12595510 [TBL] [Abstract][Full Text] [Related]
20. Serum apolipoprotein A-I, A-II and B levels and their discriminative values in relatives of patients with coronary artery disease. Kukita H; Hiwada K; Kokubu T Atherosclerosis; 1984; 51(2-3):261-7. PubMed ID: 6430307 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]